
Radical Numerics is an AI research lab building general biological intelligence through multimodal models trained on biological data.
Official pages and third-party coverage in one index.
radicalnumerics.ai15 items across 9 mapped pages · Crawled Sep 24, 2026
Official pages and third-party coverage in one index
Progress on our science and engineering.
NVIDIA's NVFP4 pretraining recipe: floating point fundamentals, the evolution of mixed-precision training, and the techniques that enable stable NVFP4 training.
A deep dive into TransformerEngine's implementation of the NVFP4 recipe: nvfp4 data flow, custom kernels, and systems optimizations for performant FP4 training.
Omnii's first biodefense results, spanning paraphrased pathogen detection and fitness scoring of viral variants beyond standard methods.
Join Radical Numerics to help develop general biological intelligence.
Radical Numerics - Next-generation AI lab for general biological intelligence
Radical Numerics - Next-generation AI lab for general biological intelligence
Radical Numerics, a San Francisco-based AI research lab, raises a $50 million seed round to advance multimodal models that learn directly from DNA, RNA, and proteins. The company says it will use the financing to fund hiring and continued model scaling as it develops models that learn from these biological data types.
Jun 2026 · The SaaS NewsNews article
Radical Numerics launches with a $50 million seed round to develop AI that learns directly from biological data. The San Francisco AI lab plans to apply its models to pathogen detection, drug discovery, and cancer diagnostics.
Jun 2026 · SiliconANGLENews article
Radical Numerics raises a $50 million seed round to scale next-generation AI models for biology, with applications including pathogen detection and biological design. Emergence Capital leads the financing, joined by Obvious Ventures, Triatomic Capital, Factory, and First Spark Ventures.
Jun 2026 · Pulse 2.0News article
Radical Numerics formally launches with a $50 million seed round led by Emergence Capital, and describes a research mission to apply AI to biology and pathogen defense. It also reports early commercial partnerships in cancer diagnostics.
Jun 2026 · Business WireNews article